SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000950159-14-000070
Filing Date
2014-02-13
Accepted
2014-02-13 13:53:51
Documents
1
Group Members
QUAKER BIOVENTURES CAPITAL II L.P.QUAKER BIOVENTURES CAPITAL II LLC

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II SCHEDULE 13G/A quakerbioii13g.htm SC 13G/A 117528
  Complete submission text file 0000950159-14-000070.txt   119276
Mailing Address 6320 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149
Business Address 6320 QUADRANGLE DRIVE SUITE 100 CHAPEL HILL NC 27517-8149 919-313-6617
CEMPRA, INC. (Subject) CIK: 0001461993 (see all company filings)

IRS No.: 262644445 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86624 | Film No.: 14604891
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A